首页 | 本学科首页   官方微博 | 高级检索  
检索        

食管癌内外放射治疗剂量与疗效关系的随机前瞻研究
引用本文:李德锐,陈志坚.食管癌内外放射治疗剂量与疗效关系的随机前瞻研究[J].中华放射肿瘤学杂志,1999,0(1):24-26.
作者姓名:李德锐  陈志坚
作者单位:广东省汕头大学医学院肿瘤医院
摘    要:目的研究内外放射剂量和放射治疗中食管X线片变化对中晚期食管癌局部控制和生存率的影响。方法146例食管鳞癌病人随机分外照射50Gy、外照射70Gy、外照射50Gy+腔内照射6Gy、外照射50Gy+腔内照射12Gy,2分次4个组,分析各剂量组生存率和外放射40Gy时X线片变化与生存率的关系;并观察59例食管癌病人术前放射治疗剂量与切除标本病理反应的关系。结果(1)各组病人的1,2,3年生存率差异无显著意义;(2)外照射40Gy时的食管X线片变化与预后有关。外照射40Gy时X线片为1,2级者和3,4级者,中位生存期分别为23个月和12个月;1,2,3年累积生存率分别为73.7%,56.4%,33.3%和48.9%,22.3%,13.0%,P=0.00026;(3)术前放射40~49Gy与50~70Gy比较,标本无癌率分别为32.2%和39.3%,差异无显著意义。结论不论是外照射还是腔内照射,在本研究采用的剂量范围内,高剂量并不能提高中晚期食管癌放射治疗效果。外照射40Gy时食管X线片变化可作为估计放射治疗预后的指标。

关 键 词:食管肿瘤/放射疗法  剂量疗效关系

Prospective randomized trial on dose response of esophageal cancer treated with radiotherapy with or without intraluminal brachytherapy
LI Derui,CHEN Zhijian,LIN Zhixiong,et al..Prospective randomized trial on dose response of esophageal cancer treated with radiotherapy with or without intraluminal brachytherapy[J].Chinese Journal of Radiation Oncology,1999,0(1):24-26.
Authors:LI Derui  CHEN Zhijian  LIN Zhixiong  
Institution:LI Derui,CHEN Zhijian,LIN Zhixiong,et al. Cancer Hospital,Medical College,Shantou University,Shantou 515031
Abstract:Objective To evaluate the results of esophageal carcinoma treated by different doses and methods of radiotherapy.Methods From July 1992 to February 1996, 146 cases of esophageal cancer were randomly allocated into four groups. Group A received 50Gy of external radiation(ER),group B 70Gy ER. Group C 50Gy ER plus 6Gy of brachytherapy(BR) in one fraction, and group D 50Gy of ER plus 12Gy of BR in two fractions. Fifty nine cases who received preoperative radiation were used to investigate the relation between radiation dose and histopathologic response. Results (1) Short term results evaluated by barium examination and 3 year survival rate analyzed by the Kaplan Meier test did not show any significant difference among these four groups, (2) All patients had their esophograms taken when 40Gy of ER. Those who had favorable X ray findings gave better survival than those who had unfavorable ones (1 2 and 3 year cumulative survivals: 73.7%, 56.4 %, and 33.3% vs 48.9 %, 22.3%, and 13.0%, respectively). (Log rank test P = 0.00026). (3)Pathological study confirmed that higher dose radiation did not significantly increase the response rate. Conclusions The higher doses used in this study, either ER or BR, do not improve the outcome advanced thoracic esophageal cancer. It seems that barium examination performed of at 40Gy ER is useful to predict the possibility of local control and long term survival.
Keywords:Esophageal neoplasms/radiotherapy    Dose response  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号